| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.055 | 0.9 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |